CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)-RELATED OUTCOMES AND COSTS FOR PATIENTS ON COMBINATION FLUTICASONE PROPIONATE-SALMETEROL XINAFOATE 250/50MCG VERSUS ANTICHOLINERGICS IN A COPD-COMORBID DEPRESSION/ANXIETY POPULATION: